Tiziana Life Sciences Ltd (NASDAQ:TLSA) shares, rose in value, with the stock price up by 20.22% to the previous day’s close as strong demand from buyers drove the stock to $1.07.
Actively observing the price movement in the last trading, the stock closed the session at $0.89, falling within a range of $0.872 and $1.095. The value of beta (5-year monthly) was 0.16. Referring to stock’s 52-week performance, its high was $1.91, and the low was $0.49. On the whole, TLSA has fluctuated by -22.74% over the past month.
With the market capitalization of Tiziana Life Sciences Ltd currently standing at about $118.41 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2020-Sep-29.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TLSA’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of TLSA currently trading nearly 8.21% and -0.08% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 53.21, while the 7-day volatility ratio is showing 13.90% which for the 30-day chart, stands at 13.73%. Furthermore, Tiziana Life Sciences Ltd (TLSA)’s beta value is 0.43, and its average true range (ATR) is 0.14.
A comparison of Tiziana Life Sciences Ltd (TLSA) with its peers suggests the former has fared considerably weaker in the market. TLSA showed an intraday change of 20.22% in last session, and over the past year, it grew by 94.37%%.
Data on historical trading for Tiziana Life Sciences Ltd (NASDAQ:TLSA) indicates that the trading volumes over the past 10 days have averaged 0.31 and over the past 3 months, they’ve averaged 957.82K. According to company’s latest data on outstanding shares, there are 102.27 million shares outstanding.
Nearly 35.15% of Tiziana Life Sciences Ltd’s shares belong to company insiders and institutional investors own 0.91% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.75 million shares as on 2025-03-31, resulting in a short ratio of 0.71. According to the data, the short interest in Tiziana Life Sciences Ltd (TLSA) stood at 97.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.57 million. The stock has risen by 53.69% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TLSA stock heading into the next quarter.
